Kawahara and collaborators reported the use of proteomic profiling through iTRAQ for identifying a number of proteins differentially abundant between cancerous and normal pancreatic duct epithelium, with higher abundance of dihydropyrimidinase-like 3 (DPYSL3) in human pancreatic cancer (86). This evidence concerns the gene DPYSL3 and familial pancreatic carcinoma.